Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CITRAFLEET POLVO PARA SOLUCION ORAL EN SOBRES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/CITRAFLEET POLVO PARA SOLUCION ORAL EN SOBRES

Approved

STANDARD

CITRAFLEET POLVO PARA SOLUCION ORAL EN SOBRES

Casen Recordati S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 12, 2023
Approval ID: 17c9530027943fde
Company: Casen Recordati S.L.
Type: Standard

Approval Details

Approval Id: 17c9530027943fde
Drug Cima Aemps Name: CITRAFLEET POLVO PARA SOLUCION ORAL EN SOBRES
Register Number: 5073317IP1
Holder Company Name: Casen Recordati S.L.
Marketing Company Name: Euromed Pharma Spain S.L.
Authorization Date: 2023-06-12
Dosage Form: POLVO PARA SOLUCIÓN ORAL
Dose: 10 mg/10970 mg/3500 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Casen Recordati S.L.

Active Ingredients

PICOSULFATO SODIO

0,01 g

MAGNESIO OXIDO

3,5 g

CITRICO ACIDO ANHIDRO

10,97 g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 12, 2023

Approval ID

17c9530027943fde

Type

Standard

Back to CIMA-AEMPS Approvals